ORYZON GENOMICS, S.A.

Organization

BARCELONA, ES

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods to determine KDM1A target engagement and chemoprobes useful...
- Patent number 12,195,783
- Issue date Jan 14, 2025
- Oryzon Genomics S.A.
- Elena Carceller González
- G01 - MEASURING TESTING
Information Patent Grant
Methods to determine KDM1A target engagement and chemoprobes useful...
- Patent number 11,034,991
- Issue date Jun 15, 2021
- Oryzon Genomics S.A.
- Elena Carceller González
- G01 - MEASURING TESTING
Information Patent Grant
Combinations of LSD1 inhibitors for the treatment of hematological...
- Patent number 11,013,698
- Issue date May 25, 2021
- Oryzon Genomics S.A.
- Filippo Ciceri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating multiple sclerosis employing a LSD1-inhibitor
- Patent number 10,780,081
- Issue date Sep 22, 2020
- ORYZON GENOMICS, SA
- Tamara Maes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 10,329,256
- Issue date Jun 25, 2019
- ORYZON GENOMICS, SA
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combinations of LSD1 inhibitors for use in the treatment of solid t...
- Patent number 10,265,279
- Issue date Apr 23, 2019
- ORYZON GENOMICS, SA
- Mark D. Demario
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...
- Patent number 10,233,178
- Issue date Mar 19, 2019
- ORYZON GENOMICS, SA
- Alberto Ortega Muñoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms
- Patent number 10,221,125
- Issue date Mar 5, 2019
- ORYZON GENOMICS, SA
- Ralph Diodone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 10,214,477
- Issue date Feb 26, 2019
- Oryzon Genomics S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lysine specific demethylase-1 inhibitors and their use
- Patent number 10,202,330
- Issue date Feb 12, 2019
- ORYZON GENOMICS, SA
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 9,944,601
- Issue date Apr 17, 2018
- ORYZON GENOMICS, S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lysine demethylase inhibitors for myeloproliferative disorders
- Patent number 9,908,859
- Issue date Mar 6, 2018
- Oryzon Genomics, S.A.
- Jonathan Alleman Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lysine demethylase inhibitors for diseases and disorders associated...
- Patent number 9,790,196
- Issue date Oct 17, 2017
- ORYZON GENOMICS S.A.
- Jonathan A. Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...
- Patent number 9,708,309
- Issue date Jul 18, 2017
- Oryzon Genomics, S.A.
- Alberto Ortega Muñoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamine derivatives useful as LSD1 inhibitors
- Patent number 9,676,701
- Issue date Jun 13, 2017
- Oryzon Genomics, S.A.
- Matthew Colin Thor Fyfe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 9,670,136
- Issue date Jun 6, 2017
- ORYZON GENOMICS S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for...
- Patent number 9,616,058
- Issue date Apr 11, 2017
- Oryzon Genomics, S.A.
- Julio Cesar Castro Palomino Laria
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 9,487,512
- Issue date Nov 8, 2016
- Oryzon Genomics S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
- Patent number 9,469,597
- Issue date Oct 18, 2016
- Oryzon Genomics S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lysine demethylase inhibitors for diseases and disorders associated...
- Patent number 9,186,337
- Issue date Nov 17, 2015
- Oryzon Genomics S.A.
- Jonathan Alleman Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...
- Patent number 9,181,198
- Issue date Nov 10, 2015
- ORYZON GENOMICS S.A.
- Alberto Ortega Muñoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lysine specific demethylase-1 inhibitors and their use
- Patent number 9,149,447
- Issue date Oct 6, 2015
- Oryzon Genomics S.A.
- Alberto Ortega Muñoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamine inhibitors of oxidases
- Patent number 9,061,966
- Issue date Jun 23, 2015
- ORYZON GENOMICS S.A.
- Julio Castro-Palomino Laria
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamine derivatives useful as LSD1 inhibitors
- Patent number 9,006,449
- Issue date Apr 14, 2015
- Oryzon Genomics, S.A.
- Matthew Colin Thor Fyfe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenylcyclopropylamine derivatives and their medical use
- Patent number 8,993,808
- Issue date Mar 31, 2015
- Oryzon Genomics, S.A.
- Nathalie Guibourt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and th...
- Patent number 8,946,296
- Issue date Feb 3, 2015
- Oryzon Genomics S.A.
- Alberto Ortega Muñoz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lysine Specific Demethylase-1 inhibitors and their use
- Patent number 8,859,555
- Issue date Oct 14, 2014
- Oryzon Genomics S.A.
- Alberto Ortega Munoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lysine specific demethylase-1 inhibitors and their use
- Patent number 8,722,743
- Issue date May 13, 2014
- Oryzon Genomics S.A.
- Alberto Ortega Munoz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxidase inhibitors and their use
- Patent number 8,524,717
- Issue date Sep 3, 2013
- Oryzon Genomics, S.A.
- Nathalie Guibourt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Molecular diagnostic method for dementia with lewy bodies
- Patent number 7,745,127
- Issue date Jun 29, 2010
- Oryzon Genomics, S.A.
- Tamara Maes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
COMBINATIONS OF LSD1 INHIBITORS FOR TREATING MYELOID CANCERS
- Publication number 20250073232
- Publication date Mar 6, 2025
- Oryzon Genomics, S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING BEHAVIOR ALTERATIONS
- Publication number 20240277673
- Publication date Aug 22, 2024
- Oryzon Genomics, S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS
- Publication number 20240226069
- Publication date Jul 11, 2024
- Oryzon Genomics, S.A.
- Carlos Manuel BUESA ARJOL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS
- Publication number 20230026909
- Publication date Jan 26, 2023
- Oryzon Genomics, S.A.
- Elena CARCELLER GONZÁLEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL...
- Publication number 20220389478
- Publication date Dec 8, 2022
- Oryzon Genomics S.A.
- Elena CARCELLER GONZÁLEZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID T...
- Publication number 20220378722
- Publication date Dec 1, 2022
- Oryzon Genomics, S.A.
- Mark D. DEMARIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL...
- Publication number 20220331265
- Publication date Oct 20, 2022
- Oryzon Genomics S.A.
- Filippo CICERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOL...
- Publication number 20220298156
- Publication date Sep 22, 2022
- Oryzon Genomics, S.A.
- Elena CARCELLER GONZÁLEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS
- Publication number 20220288039
- Publication date Sep 15, 2022
- Oryzon Genomics, S.A.
- Carlos Manuel BUESA ARJOL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY
- Publication number 20220175698
- Publication date Jun 9, 2022
- Oryzon Genomics, S.A.
- Filippo CICERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER USING...
- Publication number 20220151999
- Publication date May 19, 2022
- Oryzon Genomics, S.A.
- Carlos Manuel BUESA ARJOL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE PHARMACEUTICAL FORMULATION
- Publication number 20210228490
- Publication date Jul 29, 2021
- Oryzon Genomics, S.A.
- Reto MAURER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS
- Publication number 20200339569
- Publication date Oct 29, 2020
- Oryzon Genomics, S.A.
- Elena CARCELLER GONZÁLEZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING BEHAVIOR ALTERATIONS
- Publication number 20200323828
- Publication date Oct 15, 2020
- Oryzon Genomics, S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE EXPRESSION BIOMARKERS FOR PERSONALIZED CANCER CARE TO EPIGENET...
- Publication number 20190153538
- Publication date May 23, 2019
- Oryzon Genomics, S.A.
- Wei-Yi CHENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF TREATING MULTIPLE SCHLEROSIS EMPLOYING A LSD1-INHIBITOR
- Publication number 20190083469
- Publication date Mar 21, 2019
- Oryzon Genomics, S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL...
- Publication number 20190085372
- Publication date Mar 21, 2019
- Oryzon Genomics S.A.
- Elena CARCELLER GONZÁLEZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL...
- Publication number 20190083417
- Publication date Mar 21, 2019
- Oryzon Genomics S.A.
- Filippo CICERI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20180354902
- Publication date Dec 13, 2018
- Oryzon Genomics, S.A.
- Alberto ORTEGA MUÑOZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIOMARKERS ASSOCIATED WITH LSD1 INHIBITORS AND USES THEREOF
- Publication number 20180284095
- Publication date Oct 4, 2018
- Oryzon Genomics, S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR...
- Publication number 20180127406
- Publication date May 10, 2018
- Oryzon Genomics S.A.
- Alberto ORTEGA MUÑOZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS
- Publication number 20180086692
- Publication date Mar 29, 2018
- Oryzon Genomics, S.A.
- Ralph DIODONE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20180079709
- Publication date Mar 22, 2018
- Oryzon Genomics S.A.
- Alberto ORTEGA MUÑOZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLI...
- Publication number 20170209432
- Publication date Jul 27, 2017
- Oryzon Genomics S.A.
- Matthew Colin Thor FYFE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20170008844
- Publication date Jan 12, 2017
- Oryzon Genomics, S.A.
- Alberto ORTEGA MUÑOZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20160368857
- Publication date Dec 22, 2016
- Oryzon Genomics S.A.
- Alberto ORTEGA MUÑOZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEAS...
- Publication number 20160081947
- Publication date Mar 24, 2016
- ORYZON GENOMICS S.A.
- Tamara MAES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS
- Publication number 20160052865
- Publication date Feb 25, 2016
- ORYZON GENOMICS S.A.
- Matthew Colin Thor FYFE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE
- Publication number 20160045456
- Publication date Feb 18, 2016
- ORYZON GENOMICS S.A.
- Nathalie GUIBOURT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYCLOPROPYLAMINE INHIBITORS OF OXIDASES
- Publication number 20160000768
- Publication date Jan 7, 2016
- Oryzon Genomics S.A.
- Julio Castro-Palomino Laria
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
79170803 - ORYZON
- Serial number 79170803
- Registration number 4916133
- Filing date Apr 17, 2015
- ORYZON GENOMICS, S.A.
- 42 - Scientific and technological services and research and design relating thereto

ORYZON GENOMICS, S.A.

Organization

Patents Grantslast 30 patents

Methods to determine KDM1A target engagement and chemoprobes useful...

Methods to determine KDM1A target engagement and chemoprobes useful...

Combinations of LSD1 inhibitors for the treatment of hematological...

Method of treating multiple sclerosis employing a LSD1-inhibitor

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Combinations of LSD1 inhibitors for use in the treatment of solid t...

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...

Solid forms

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Lysine specific demethylase-1 inhibitors and their use

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Lysine demethylase inhibitors for myeloproliferative disorders

Lysine demethylase inhibitors for diseases and disorders associated...

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...

Cyclopropylamine derivatives useful as LSD1 inhibitors

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for...

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors

Lysine demethylase inhibitors for diseases and disorders associated...

Arylcyclopropylamine based demethylase inhibitors of LSD1 and their...

Lysine specific demethylase-1 inhibitors and their use

Cyclopropylamine inhibitors of oxidases

Cyclopropylamine derivatives useful as LSD1 inhibitors

Phenylcyclopropylamine derivatives and their medical use

Substituted heteroaryl- and aryl-cyclopropylamine acetamides and th...

Lysine Specific Demethylase-1 inhibitors and their use

Lysine specific demethylase-1 inhibitors and their use

Oxidase inhibitors and their use

Molecular diagnostic method for dementia with lewy bodies

Patents Applicationslast 30 patents

COMBINATIONS OF LSD1 INHIBITORS FOR TREATING MYELOID CANCERS

METHODS OF TREATING BEHAVIOR ALTERATIONS

VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS

1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS

METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL...

COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID T...

COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL...

3-(2-(HETEROARYL)-PYRIDIN-4-YL)-5-(TRIFLUOROMETHYL)-1,2,4-OXADIAZOL...

VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS

COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY

METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER USING...

STABLE PHARMACEUTICAL FORMULATION

1,2,4-OXADIAZOLE DERIVATIVES AS HISTONE DEACETYLASE 6 INHIBITORS

METHODS OF TREATING BEHAVIOR ALTERATIONS

GENE EXPRESSION BIOMARKERS FOR PERSONALIZED CANCER CARE TO EPIGENET...

METHOD OF TREATING MULTIPLE SCHLEROSIS EMPLOYING A LSD1-INHIBITOR

METHODS TO DETERMINE KDM1A TARGET ENGAGEMENT AND CHEMOPROBES USEFUL...

COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL...

(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

BIOMARKERS ASSOCIATED WITH LSD1 INHIBITORS AND USES THEREOF

ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR...

SOLID FORMS

(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE OR LYMPHOPROLI...

(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

SELECTIVE LSD1 AND DUAL LSD1/MAO-B INHIBITORS FOR MODULATING DISEAS...

CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS

PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE

CYCLOPROPYLAMINE INHIBITORS OF OXIDASES

Trademarklast 30 trademarks

79170803 - ORYZON